Want to create an interactive transcript for this episode?
Podcast: Measure Success Podcast
Episode: Redefining Protein Biomanufacturing and Drug Discovery
Description: Sean McClain is the Founder and CEO of AbSci, a synthetic biology company that uses a patented Protein Printing™ technology to transform traditional biomanufacturing and drug discovery. Sean has spent his career investigating and developing technologies that drive down drug costs, speed up drug development, and enable the manufacture of next-generation biotherapeutics that wouldn't make it to market otherwise. Under Sean's leadership, AbSci has grown to more than 100 employees, raised more than $100 million in capital, and has established partnerships with industry-leading pharmaceutical companies to develop biomanufacturing technologies for life-saving drugs. In 2019, Sean was recognized by Forbes as pa...